{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:30:27Z","timestamp":1788863427082,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-022-03485-6","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T02:05:51Z","timestamp":1647828351000},"page":"4005-4015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Small bowel neuroendocrine neoplasm: what surgeons want to know"],"prefix":"10.1007","volume":"47","author":[{"given":"Akshya","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3788-2871","authenticated-orcid":false,"given":"Meghan G.","family":"Lubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason B.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry J.","family":"Pickhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"3485_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","volume":"249","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 2009; 249:63-71","journal-title":"Ann Surg"},{"key":"3485_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.path.2020.04.002","volume":"13","author":"RS Gonzalez","year":"2020","unstructured":"Gonzalez RS. Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms. Surg Pathol Clin 2020; 13:377-397","journal-title":"Surg Pathol Clin"},{"key":"3485_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.bpg.2005.05.009","volume":"19","author":"KM Hoffmann","year":"2005","unstructured":"Hoffmann KM, Furukawa M, Jensen RT. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol 2005; 19:675-697","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"3485_CR4","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1245\/s10434-018-6676-2","volume":"25","author":"KJ Keck","year":"2018","unstructured":"Keck KJ, Maxwell JE, Utria AF, et al. The Distal Predilection of Small Bowel Neuroendocrine Tumors. Annals of surgical oncology 2018; 25:3207-3213","journal-title":"Annals of surgical oncology"},{"key":"3485_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76:182-188","journal-title":"Histopathology"},{"key":"3485_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","volume":"46","author":"JR Howe","year":"2017","unstructured":"Howe JR, Cardona K, Fraker DL, et al. The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society. Pancreas 2017; 46:715-731","journal-title":"Pancreas"},{"key":"3485_CR7","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, et al. One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008; 26:3063-3072","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"3485_CR8","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00268-011-1296-z","volume":"36","author":"O Norl\u00e9n","year":"2012","unstructured":"Norl\u00e9n O, St\u00e5lberg P, \u00d6berg K, et al. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. World J Surg 2012; 36:1419-1431","journal-title":"World J Surg"},{"key":"3485_CR9","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/bjs.7649","volume":"98","author":"K Landerholm","year":"2011","unstructured":"Landerholm K, Zar N, Andersson RE, Falkmer SE, J\u00e4rhult J. Survival and prognostic factors in patients with small bowel carcinoid tumour. The British journal of surgery 2011; 98:1617-1624","journal-title":"The British journal of surgery"},{"key":"3485_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jamcollsurg.2016.12.032","volume":"224","author":"EA Woltering","year":"2017","unstructured":"Woltering EA, Voros BA, Beyer DT, et al. Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution. Journal of the American College of Surgeons 2017; 224:434-447","journal-title":"Journal of the American College of Surgeons"},{"key":"3485_CR11","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1245\/s10434-010-1154-5","volume":"17","author":"SC Mayo","year":"2010","unstructured":"Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Annals of surgical oncology 2010; 17:3129-3136","journal-title":"Annals of surgical oncology"},{"key":"3485_CR12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.surg.2018.09.006","volume":"165","author":"JF Tierney","year":"2019","unstructured":"Tierney JF, Chivukula SV, Wang X, et al. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery 2019; 165:644-651","journal-title":"Surgery"},{"key":"3485_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97:934-959","journal-title":"Cancer"},{"key":"3485_CR14","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1007\/s00261-019-01945-0","volume":"44","author":"A Gupta","year":"2019","unstructured":"Gupta A, Lubner MG, Wertz RM, Foley E, Loeffler A, Pickhardt PJ. CT detection of primary and metastatic ileal carcinoid tumor: rates of missed findings and associated delay in clinical diagnosis. Abdominal radiology (New York) 2019; 44:2721-2728","journal-title":"Abdominal radiology (New York)"},{"key":"3485_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.amjsurg.2004.01.019","volume":"187","author":"S Toth-Fejel","year":"2004","unstructured":"Toth-Fejel S, Pommier RF. Relationships among delay of diagnosis, extent of disease, and survival in patients with abdominal carcinoid tumors. American journal of surgery 2004; 187:575-579","journal-title":"American journal of surgery"},{"key":"3485_CR16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00261-020-02773-3","volume":"46","author":"S Malla","year":"2021","unstructured":"Malla S, Kumar P, Madhusudhan KS. Radiology of the neuroendocrine neoplasms of the gastrointestinal tract: a comprehensive review. Abdominal radiology (New York) 2021; 46:919-935","journal-title":"Abdominal radiology (New York)"},{"key":"3485_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1148\/rg.271065169","volume":"27","author":"AD Levy","year":"2007","unstructured":"Levy AD, Sobin LH. Gastrointestinal Carcinoids: Imaging Features with Clinicopathologic Comparison. RadioGraphics 2007; 27:237-257","journal-title":"RadioGraphics"},{"key":"3485_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.soc.2019.11.006","volume":"29","author":"AT Scott","year":"2020","unstructured":"Scott AT, Howe JR. Management of Small Bowel Neuroendocrine Tumors. Surg Oncol Clin N Am 2020; 29:223-241","journal-title":"Surg Oncol Clin N Am"},{"key":"3485_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","volume":"9","author":"IMP Modlin","year":"2008","unstructured":"Modlin IMP, Oberg KP, Chung DCMD, et al. Gastroenteropancreatic neuroendocrine tumours. The lancet oncology 2008; 9:61-72","journal-title":"The lancet oncology"},{"key":"3485_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000499049","volume":"96","author":"EM Wolin","year":"2019","unstructured":"Wolin EM, Benson Iii AB. Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review. Oncology 2019; 96:273-289","journal-title":"Oncology"},{"key":"3485_CR21","doi-asserted-by":"publisher","first-page":"8126087","DOI":"10.1155\/2018\/8126087","volume":"2018","author":"P Di Giacinto","year":"2018","unstructured":"Di Giacinto P, Rota F, Rizza L, et al. Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors. International Journal of Endocrinology 2018; 2018:8126087","journal-title":"International Journal of Endocrinology"},{"key":"3485_CR22","doi-asserted-by":"publisher","first-page":"e0124884","DOI":"10.1371\/journal.pone.0124884","volume":"10","author":"X Yang","year":"2015","unstructured":"Yang X, Yang Y, Li Z, et al. Diagnostic value of circulating chromogranin a for neuroendocrine tumors: a systematic review and meta-analysis. PLoS One 2015; 10:e0124884","journal-title":"PLoS One"},{"key":"3485_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/000456320203900605","volume":"39","author":"RS Carling","year":"2002","unstructured":"Carling RS, Degg TJ, Allen KR, Bax ND, Barth JH. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease. Ann Clin Biochem 2002; 39:577-582","journal-title":"Ann Clin Biochem"},{"key":"3485_CR24","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2214\/AJR.21.26132","volume":"217","author":"EM Lawrence","year":"2021","unstructured":"Lawrence EM, Pickhardt PJ. Water-Soluble Contrast Challenge for Suspected Small-Bowel Obstruction: Technical Success Rate, Accuracy, and Clinical Outcomes. AJR American journal of roentgenology 2021; 217:1365-1366","journal-title":"AJR American journal of roentgenology"},{"key":"3485_CR25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.rcl.2021.05.006","volume":"59","author":"SJ Galgano","year":"2021","unstructured":"Galgano SJ, Wei B, Rose JB. PET Imaging of Neuroendocrine Tumors. The Radiologic clinics of North America 2021; 59:789-799","journal-title":"The Radiologic clinics of North America"},{"key":"3485_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2214\/AJR.12.9758","volume":"201","author":"D Ganeshan","year":"2013","unstructured":"Ganeshan D, Bhosale P, Yang T, Kundra V. Imaging Features of Carcinoid Tumors of the Gastrointestinal Tract. American Journal of Roentgenology 2013; 201:773-786","journal-title":"American Journal of Roentgenology"},{"key":"3485_CR27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.rcl.2020.07.008","volume":"58","author":"SJ Galgano","year":"2020","unstructured":"Galgano SJ, Sharbidre K, Morgan DE. Multimodality Imaging of Neuroendocrine Tumors. Radiologic clinics of North America 2020; 58:1147-1159","journal-title":"Radiologic clinics of North America"},{"key":"3485_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4329\/wjr.v7.i9.220","volume":"7","author":"D Bonekamp","year":"2015","unstructured":"Bonekamp D, Raman SP, Horton KM, Fishman EK. Role of computed tomography angiography in detection and staging of small bowel carcinoid tumors. World journal of radiology 2015; 7:220-235","journal-title":"World journal of radiology"},{"key":"3485_CR29","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1007\/s10620-011-1773-0","volume":"56","author":"FA Hakim","year":"2011","unstructured":"Hakim FA, Alexander JA, Huprich JE, Grover M, Enders FT. CT-enterography may identify small bowel tumors not detected by capsule endoscopy: eight years experience at Mayo Clinic Rochester. Digestive diseases and sciences 2011; 56:2914-2919","journal-title":"Digestive diseases and sciences"},{"key":"3485_CR30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1148\/rg.263055162","volume":"26","author":"SR Paulsen","year":"2006","unstructured":"Paulsen SR, Huprich JE, Fletcher JG, et al. CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics 2006; 26:641-657; discussion 657-662","journal-title":"Radiographics"},{"key":"3485_CR31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00261-020-02410-z","volume":"45","author":"S Kim","year":"2020","unstructured":"Kim S, Marcus R, Wells ML, et al. The evolving role of imaging for small bowel neuroendocrine neoplasms: estimated impact of imaging and disease-free survival in a retrospective observational study. Abdominal radiology (New York) 2020; 45:623-631","journal-title":"Abdominal radiology (New York)"},{"key":"3485_CR32","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1148\/radiol.11110143","volume":"260","author":"JE Huprich","year":"2011","unstructured":"Huprich JE, Fletcher JG, Fidler JL, et al. Prospective blinded comparison of wireless capsule endoscopy and multiphase CT enterography in obscure gastrointestinal bleeding. Radiology 2011; 260:744-751","journal-title":"Radiology"},{"key":"3485_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jso.24825","volume":"117","author":"N Manguso","year":"2018","unstructured":"Manguso N, Gangi A, Johnson J, et al. The role of pre-operative imaging and double balloon enteroscopy in the surgical management of small bowel neuroendocrine tumors: Is it necessary? Journal of surgical oncology 2018; 117:207-212","journal-title":"Journal of surgical oncology"},{"key":"3485_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jmri.1182","volume":"14","author":"TR Bader","year":"2001","unstructured":"Bader TR, Semelka RC, Chiu VC, Armao DM, Woosley JT. MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver. Journal of magnetic resonance imaging : JMRI 2001; 14:261-269","journal-title":"Journal of magnetic resonance imaging : JMRI"},{"key":"3485_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.clinimag.2015.12.016","volume":"40","author":"A Dohan","year":"2016","unstructured":"Dohan A, El Fattach H, Barat M, et al. Neuroendocrine tumors of the small bowel: evaluation with MR-enterography. Clinical imaging 2016; 40:541-547","journal-title":"Clinical imaging"},{"key":"3485_CR36","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2967\/jnumed.116.186361","volume":"58","author":"L Bodei","year":"2017","unstructured":"Bodei L, Ambrosini V, Herrmann K, Modlin I. Current Concepts in (68)Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017; 58:1718-1726","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"key":"3485_CR37","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, et al. One Hundred Years After \u201cCarcinoid\u201d: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States. Journal of Clinical Oncology 2008; 26:3063-3072","journal-title":"Journal of Clinical Oncology"},{"key":"3485_CR38","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11154-017-9437-9","volume":"18","author":"K Alexandraki","year":"2017","unstructured":"Alexandraki K, Angelousi A, Boutzios G, Kyriakopoulos G, Rontogianni D, Kaltsas G. Management of neuroendocrine tumors of unknown primary. Rev Endocr Metab Disord 2017; 18:423-431","journal-title":"Rev Endocr Metab Disord"},{"key":"3485_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00259-009-1205-y","volume":"37","author":"V Prasad","year":"2010","unstructured":"Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP. Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET\/CT. European journal of nuclear medicine and molecular imaging 2010; 37:67-77","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"3485_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2214\/AJR.18.19881","volume":"211","author":"Y Sanli","year":"2018","unstructured":"Sanli Y, Garg I, Kandathil A, et al. Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET\/CT. American Journal of Roentgenology 2018; 211:267-277","journal-title":"American Journal of Roentgenology"},{"key":"3485_CR41","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1097\/RLU.0000000000002487","volume":"44","author":"M Clark","year":"2019","unstructured":"Clark M, Nathan M, Broski SM. Multifocal Small Bowel Carcinoid: Evaluation by 68Ga-DOTATATE PET. Clinical nuclear medicine 2019; 44:e308-e310","journal-title":"Clinical nuclear medicine"},{"key":"3485_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1590\/S1679-45082015AO3380","volume":"13","author":"I Negoi","year":"2015","unstructured":"Negoi I, Paun S, Hostiuc S, et al. Most small bowel cancers are revealed by a complication. Einstein (Sao Paulo, Brazil) 2015; 13:500-505","journal-title":"Einstein (Sao Paulo, Brazil)"},{"key":"3485_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2214\/AJR.18.21025","volume":"213","author":"A Gupta","year":"2019","unstructured":"Gupta A, Lubner MG, Menias CO, Mellnick VM, Elsayes KM, Pickhardt PJ. Multimodality Imaging of Ileal Neuroendocrine (Carcinoid) Tumor. American Journal of Roentgenology 2019; 213:45-53","journal-title":"American Journal of Roentgenology"},{"key":"3485_CR44","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00268-002-6630-z","volume":"26","author":"P Hellman","year":"2002","unstructured":"Hellman P, Lundstr\u00f6m T, \u00d6hrvall U, et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World Journal of Surgery 2002; 26:991-997","journal-title":"World Journal of Surgery"},{"key":"3485_CR45","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.dld.2011.04.021","volume":"43","author":"C Le Roux","year":"2011","unstructured":"Le Roux C, Lombard-Bohas C, Delmas C, et al. Relapse factors for ileal neuroendocrine tumours after curative surgery: A retrospective French multicentre study. Digestive and Liver Disease 2011; 43:828-833","journal-title":"Digestive and Liver Disease"},{"key":"3485_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000464292","volume":"105","author":"S Partelli","year":"2017","unstructured":"Partelli S, Bartsch DK, Capdevila J, et al. ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours. Neuroendocrinology 2017; 105:255-265","journal-title":"Neuroendocrinology"},{"key":"3485_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.humpath.2016.05.023","volume":"56","author":"JC Walsh","year":"2016","unstructured":"Walsh JC, Schaeffer DF, Kirsch R, et al. Ileal \"carcinoid\" tumors-small size belies deadly intent: high rate of nodal metastasis in tumors <\/=1 cm in size. Human pathology 2016; 56:123-127","journal-title":"Human pathology"},{"key":"3485_CR48","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1245\/s10434-020-09566-4","volume":"28","author":"CG Tran","year":"2021","unstructured":"Tran CG, Sherman SK, Howe JR. The Landmark Series: Management of Small Bowel Neuroendocrine Tumors. Annals of surgical oncology 2021; 28:2741-2751","journal-title":"Annals of surgical oncology"},{"key":"3485_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2214\/ajr.164.2.7839976","volume":"164","author":"L Pantongrag-Brown","year":"1995","unstructured":"Pantongrag-Brown L, Buetow PC, Carr NJ, Lichtenstein JE, Buck JL. Calcification and fibrosis in mesenteric carcinoid tumor: CT findings and pathologic correlation. AJR American journal of roentgenology 1995; 164:387-391","journal-title":"AJR American journal of roentgenology"},{"key":"3485_CR50","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.ejrad.2015.06.024","volume":"84","author":"DR Albanus","year":"2015","unstructured":"Albanus DR, Apitzsch J, Erdem Z, et al. Clinical value of 68Ga-DOTATATE-PET\/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET). European journal of radiology 2015; 84:1866-1872","journal-title":"European journal of radiology"},{"key":"3485_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00268-020-05710-z","volume":"45","author":"J Hallet","year":"2021","unstructured":"Hallet J, Law C. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors. World J Surg 2021; 45:197-202","journal-title":"World J Surg"},{"key":"3485_CR52","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3390\/jcm9072319","volume":"9","author":"S Deguelte","year":"2020","unstructured":"Deguelte S, Perrier M, Hammoutene C, Cadiot G, Kianmanesh R. Surgery and Perioperative Management in Small Intestinal Neuroendocrine Tumors. J Clin Med 2020; 9","journal-title":"J Clin Med"},{"key":"3485_CR53","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1007\/s002680010232","volume":"24","author":"U Ohrvall","year":"2000","unstructured":"Ohrvall U, Eriksson B, Juhlin C, et al. Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg 2000; 24:1402-1408","journal-title":"World J Surg"},{"key":"3485_CR54","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.3390\/cancers13215473","volume":"13","author":"A Pasquer","year":"2021","unstructured":"Pasquer A, Walter T, Milot L, Hervieu V, Poncet G. Principles of Surgical Management of Small Intestinal NET. Cancers (Basel) 2021; 13","journal-title":"Cancers (Basel)"},{"key":"3485_CR55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11605-015-2953-6","volume":"20","author":"AK Clift","year":"2016","unstructured":"Clift AK, Faiz O, Al-Nahhas A, et al. Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours. J Gastrointest Surg 2016; 20:180-188; discussion 188","journal-title":"J Gastrointest Surg"},{"key":"3485_CR56","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1148\/radiol.13121628","volume":"268","author":"G d\u2019Assignies","year":"2013","unstructured":"d\u2019Assignies G, Fina P, Bruno O, et al. High Sensitivity of Diffusion-weighted MR Imaging for the Detection of Liver Metastases from Neuroendocrine Tumors: Comparison with T2-weighted and Dynamic Gadolinium-enhanced MR Imaging. Radiology 2013; 268:390-399","journal-title":"Radiology"},{"key":"3485_CR57","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.surg.2014.08.090","volume":"156","author":"O Norl\u00e9n","year":"2014","unstructured":"Norl\u00e9n O, Edfeldt K, Akerstrom G, et al. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling. Surgery 2014; 156:1512-1521; discussion 1521-1512","journal-title":"Surgery"},{"key":"3485_CR58","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1007\/s00330-020-07554-6","volume":"31","author":"N Deleval","year":"2021","unstructured":"Deleval N, Pesque L, Dieudonn\u00e9 A, et al. Prognostic impact of bone metastases detected by (18)F-DOPA PET in patients with metastatic midgut neuroendocrine tumors. European radiology 2021; 31:4166-4174","journal-title":"European radiology"},{"key":"3485_CR59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000457954","volume":"106","author":"M Scharf","year":"2018","unstructured":"Scharf M, Petry V, Daniel H, Rinke A, Gress TM. Bone Metastases in Patients with Neuroendocrine Neoplasm: Frequency and Clinical, Therapeutic, and Prognostic Relevance. Neuroendocrinology 2018; 106:30-37","journal-title":"Neuroendocrinology"},{"key":"3485_CR60","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000497183","volume":"108","author":"K Daskalakis","year":"2019","unstructured":"Daskalakis K, Tsoli M, Srirajaskanthan R, et al. Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance. Neuroendocrinology 2019; 108:308-316","journal-title":"Neuroendocrinology"},{"key":"3485_CR61","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1200\/JCO.2015.64.0987","volume":"34","author":"SM Sadowski","year":"2016","unstructured":"Sadowski SM, Neychev V, Millo C, et al. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography\/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; 34:588-596","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"3485_CR62","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.27159","author":"SJ Galgano","year":"2022","unstructured":"Galgano SJ, Iravani A, Bodei L, El-Haddad G, Hofman MS, Kong G. Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response\u2014AJR Expert Panel Narrative Review. American Journal of Roentgenology 2022;","journal-title":"American Journal of Roentgenology"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03485-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-022-03485-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03485-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:18:44Z","timestamp":1667348324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-022-03485-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":62,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3485"],"URL":"https:\/\/doi.org\/10.1007\/s00261-022-03485-6","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AG, JL, ESR: no relevant disclosures. MGL: prior grant funding, Ethicon, Philips. PJP: advisor to Bracco, shareholder in Elucent, SHINE and Cellectar Biosciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}